Another Vaccine Rollout Sans Safety Data

More than 100,000 Chinese citizens have already been given a COVID-19 vaccine before safety trials were completed, a state-owned company behind 3 vaccine candidates said Monday, Vox reports.
Under the emergency use program launched in July, it was implied that high-risk groups would have priority access, but the criteria for participation remains a mystery.
Chinese vaccine makers’ history of scandals underscores the potential risks of a premature vaccine rollout. But if a Chinese candidate is approved for widespread use first? “It will be a pretty big propaganda victory” for Beijing, says China analyst Adam Ni.
Chinese companies are behind 4 of the 9 candidates that have made it to phase 3 clinical trials.
A growing part of China’s biomedical muscle: reforms that have quickly expanded the role of largest armed force in the world—the People’s Liberation Army—in biomedical research, Nature reports.

Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top